Brain

Natus announces integration of InVisus Pro NMUS into Natus Elite software

MIDDLETON, Wis., April 30, 2025 /PRNewswire/ -- Natus Medical Incorporated has announced its InVisus Pro Neuromuscular Ultrasound system can now…

8 months ago

XingImaging Unveils NX PET Camera to Advance Parkinson’s Disease Research

NEW HAVEN, Conn., April 30, 2025 /PRNewswire/ -- XingImaging, a MITRO company, a pioneer in advanced research imaging, radiopharmaceutical services,…

8 months ago

Annals of Family Medicine: Four New Studies Test Digital and Artificial Intelligence Screening Tools in Family Medicine

New research inĀ Annals of Family Medicine explores the use of artificial intelligence, apps, and tablets to detect dementia, heart dysfunction,…

8 months ago

MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety

Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at…

8 months ago

MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety

Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at…

8 months ago

MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety

Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at…

8 months ago

LEVEL EX LAUNCHES LEVEL ONE, A FREE MOBILE GAME TO REDEFINE TYPE 1 DIABETES ONBOARDING

Now available on iOS and Android, Level One helps newly diagnosed Type 1 Diabetics and their caregivers master insulin management…

8 months ago

LEVEL EX LAUNCHES LEVEL ONE, A FREE MOBILE GAME TO REDEFINE TYPE 1 DIABETES ONBOARDING

Now available on iOS and Android, Level One helps newly diagnosed Type 1 Diabetics and their caregivers master insulin management…

8 months ago

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025…

8 months ago

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025…

8 months ago